$OGRMF Receives Increased License Capacity

The new capacity allows for Organigram to sell 600kg of medical marijuana over the next 12-month period.

Additionally, Organigram recently completed the construction of 4 new growing rooms and is currently awaiting inspection by Health Canada. Once the growing rooms are inspected and approved, Organigram will submit amendments to Health Canada to further increase the capacity to grow and sell. The Company anticipates the rooms being approved and integrated into the production cycle by the middle of May 2015.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram’s facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.

Please visit www.organigram.ca for more information.

On Behalf of the Board of Directors of Organigram,

Denis Arsenault, Director & CEO

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors – including the availability of funds, the results of financing efforts, the results of exploration activities — that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.